Trial intelligence / Profile preview

Early Detection of Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients

NCT03231371Phase 3Completed

Start
Nov 2008
Primary completion
Jan 2011
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of adenosine in cardiac allograft vasculopathy (CAV). Started Nov 2008; status: completed.

02

Drugs

adenosine
03

Conditions

cardiac allograft vasculopathy (CAV)

Beyond the preview

Go deeper on NCT03231371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03231371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call